SUPERNUS PHARMACEUTICALS, INC. (SUPN)

SEC filing

SUPERNUS PHARMACEUTICALS, INC.

SUPN · CIK 1356576

4 · Mar 9, 2026 · GEMAYEL GEORGES sold 18.79K shares at $53.38/share ($1.0M); exercised options for 7,905 shares

GEMAYEL GEORGES sold 18.79K shares at $53.38/share ($1.0M); exercised options for 7,905 shares

FORM 4

xslF345X05/wk-form4_1773086807.xmlSEC.gov

Graphics and non-inline formats (not embedded below).